Aortic valve repair in a patient with congenital afibrinogenemia

Anesthesia and Analgesia

Volumn 101, Issue 6, 2005, Pages 1628-1630

  Lal, Adarsh B ^a   Maruthavanan, Ram ^a   Scott, Nicholas B ^a  

^a GOLDEN JUBILEE NATIONAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALFENTANIL; APROTININ; FIBRINOGEN; HIRUDIN; PANCURONIUM; TEMAZEPAM;

ADOLESCENT; AFIBRINOGENEMIA; AORTA VALVE DISEASE; ARTICLE; BLEEDING; BLOOD CLOTTING; CARDIOPULMONARY BYPASS; CASE REPORT; CRYOPRECIPITATE; HEPARINIZATION; HUMAN; MALE; PRIORITY JOURNAL; VALVULOTOMY;

EID: 28344434645     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000184186.95127.E2     Document Type: Article

References (12)

1. Neerman-Arbez M. The molecular basis of inherited afibrinogenemia. Thromb Haemost 2001;86:154-63.
2. Lak M, Keihani M, Elahi F, et al. Bleeding and thrombosis in 55 patients with inherited afibrinogenaemia. Br J Haematol 1999; 107:204-6.
3. Chafa O, Chellali T, Sternberg C, et al. Severe hypofibrinogenemia associated with bilateral ischemic necrosis of toes and fingers. Blood Coagul Fibrinolysis 1995;6:549-52.
4. Thompson HW, Touris H, Giambartolomei S, et al. Treatment of congenital afibrinogenemia with cryoprecipitate collected through a plasmapheresis program using dedicated donors. J Clin Apher 1998;13:143-5.
5. Rodriguez RC, Buchanan GR, Clanton MS. Prophylactic cryoprecipitate in congenital afibrinogenemia. Clin Pediatr (Phila) 1988;27:543-5.
6. Henselmans JM, Meijer K, Haaxma R, et al. Recurrent spontaneous intracerebral hemorrhage in a congenitally afibrinogenemic patient: diagnostic pitfalls and therapeutic options. Stroke 1999;30:2479-82.
7. Shehata N, Blajchman M, Heddle N. Coagulation factors in FFP and cryosupernatant. Transfus Med 2001;11:391-401.
8. Zulys VJ, Teasdale SJ, Michel ER, et al. Ancrod (Arvin) as an alternative to heparin anticoagulation for cardiopulmonary bypass. Anesthesiology 1989;71:870.
9. Frumento RJ, O'Malley CM, Bennett-Guerrero E. Stroke after cardiac surgery: a retrospective analysis of the effect of aprotinin dosing regimens. Ann Thorac Surg 2003;75:479-83.
10. Bull DA, Maurer J. Aprotinin and preservation of myocardial function after ischemia-reperfusion injury. Ann Thorac Surg 2003;75:S735-9.
11. Levi M, Cromheecke ME, de Jonge E, et al. Pharmacological strategies to decrease blood loss in cardiac surgery:a meta-analysis of clinically relevant endpoints. The Lancet 1999;354:1940-7.
12. Chun R, Poon M, Haigh J, et al. Cardiac surgery in congenital afibrinogememia with thrombo-occlusive disease. J Cardiothorac Vasc Anesth 2005;19:109-17.